2Seventy Bio Inc
NASDAQ:TSVT

Watchlist Manager
2Seventy Bio Inc Logo
2Seventy Bio Inc
NASDAQ:TSVT
Watchlist
Price: 4.005 USD -3.03%
Market Cap: 206.3m USD
Have any thoughts about
2Seventy Bio Inc?
Write Note

Intrinsic Value

The intrinsic value of one TSVT stock under the Base Case scenario is 4.619 USD. Compared to the current market price of 4.005 USD, 2Seventy Bio Inc is Undervalued by 13%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TSVT Intrinsic Value
4.619 USD
Undervaluation 13%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
2Seventy Bio Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for TSVT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about TSVT?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about 2Seventy Bio Inc

Provide an overview of the primary business activities
of 2Seventy Bio Inc.

What unique competitive advantages
does 2Seventy Bio Inc hold over its rivals?

What risks and challenges
does 2Seventy Bio Inc face in the near future?

Summarize the latest earnings call
of 2Seventy Bio Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for 2Seventy Bio Inc.

Provide P/S
for 2Seventy Bio Inc.

Provide P/E
for 2Seventy Bio Inc.

Provide P/OCF
for 2Seventy Bio Inc.

Provide P/FCFE
for 2Seventy Bio Inc.

Provide P/B
for 2Seventy Bio Inc.

Provide EV/S
for 2Seventy Bio Inc.

Provide EV/GP
for 2Seventy Bio Inc.

Provide EV/EBITDA
for 2Seventy Bio Inc.

Provide EV/EBIT
for 2Seventy Bio Inc.

Provide EV/OCF
for 2Seventy Bio Inc.

Provide EV/FCFF
for 2Seventy Bio Inc.

Provide EV/IC
for 2Seventy Bio Inc.

Show me price targets
for 2Seventy Bio Inc made by professional analysts.

What are the Revenue projections
for 2Seventy Bio Inc?

How accurate were the past Revenue estimates
for 2Seventy Bio Inc?

What are the Net Income projections
for 2Seventy Bio Inc?

How accurate were the past Net Income estimates
for 2Seventy Bio Inc?

What are the EPS projections
for 2Seventy Bio Inc?

How accurate were the past EPS estimates
for 2Seventy Bio Inc?

What are the EBIT projections
for 2Seventy Bio Inc?

How accurate were the past EBIT estimates
for 2Seventy Bio Inc?

Compare the revenue forecasts
for 2Seventy Bio Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of 2Seventy Bio Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of 2Seventy Bio Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of 2Seventy Bio Inc compared to its peers.

Compare the P/E ratios
of 2Seventy Bio Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing 2Seventy Bio Inc with its peers.

Analyze the financial leverage
of 2Seventy Bio Inc compared to its main competitors.

Show all profitability ratios
for 2Seventy Bio Inc.

Provide ROE
for 2Seventy Bio Inc.

Provide ROA
for 2Seventy Bio Inc.

Provide ROIC
for 2Seventy Bio Inc.

Provide ROCE
for 2Seventy Bio Inc.

Provide Gross Margin
for 2Seventy Bio Inc.

Provide Operating Margin
for 2Seventy Bio Inc.

Provide Net Margin
for 2Seventy Bio Inc.

Provide FCF Margin
for 2Seventy Bio Inc.

Show all solvency ratios
for 2Seventy Bio Inc.

Provide D/E Ratio
for 2Seventy Bio Inc.

Provide D/A Ratio
for 2Seventy Bio Inc.

Provide Interest Coverage Ratio
for 2Seventy Bio Inc.

Provide Altman Z-Score Ratio
for 2Seventy Bio Inc.

Provide Quick Ratio
for 2Seventy Bio Inc.

Provide Current Ratio
for 2Seventy Bio Inc.

Provide Cash Ratio
for 2Seventy Bio Inc.

What is the historical Revenue growth
over the last 5 years for 2Seventy Bio Inc?

What is the historical Net Income growth
over the last 5 years for 2Seventy Bio Inc?

What is the current Free Cash Flow
of 2Seventy Bio Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for 2Seventy Bio Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
2Seventy Bio Inc

Current Assets 224.9m
Cash & Short-Term Investments 201.9m
Receivables 18.1m
Other Current Assets 4.9m
Non-Current Assets 293m
PP&E 247.2m
Intangibles 6.2m
Other Non-Current Assets 39.6m
Current Liabilities 47.2m
Accounts Payable 3m
Accrued Liabilities 43.3m
Other Current Liabilities 888k
Non-Current Liabilities 235.9m
Other Non-Current Liabilities 235.9m
Efficiency

Earnings Waterfall
2Seventy Bio Inc

Revenue
44.1m USD
Cost of Revenue
-14.8m USD
Gross Profit
29.3m USD
Operating Expenses
-211.9m USD
Operating Income
-182.6m USD
Other Expenses
26.3m USD
Net Income
-156.3m USD

Free Cash Flow Analysis
2Seventy Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

TSVT Profitability Score
Profitability Due Diligence

2Seventy Bio Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Revenue Growth Forecast
Negative 1-Year Revenue Growth
Negative Operating Income
21/100
Profitability
Score

2Seventy Bio Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

TSVT Solvency Score
Solvency Due Diligence

2Seventy Bio Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
55/100
Solvency
Score

2Seventy Bio Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TSVT Price Targets Summary
2Seventy Bio Inc

Wall Street analysts forecast TSVT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TSVT is 8.415 USD with a low forecast of 2.02 USD and a high forecast of 15.75 USD.

Lowest
Price Target
2.02 USD
50% Downside
Average
Price Target
8.415 USD
110% Upside
Highest
Price Target
15.75 USD
293% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for TSVT?

Click here to dive deeper.

Dividends

2Seventy Bio Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TSVT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

2Seventy Bio Inc Logo
2Seventy Bio Inc

Country

United States of America

Industry

Biotechnology

Market Cap

212.7m USD

Dividend Yield

0%

Description

2seventy Bio, Inc. operates as cell and gene therapy company. The company is headquartered in Cambridge, Massachusetts and currently employs 437 full-time employees. The company went IPO on 2021-10-18. The firm is focused on the research, development, and commercialization of transformative treatments for cancer. Its approach combines its expertise in T cell engineering technology and lentiviral vector gene delivery approaches, experience in research, development, and manufacturing of cell therapies and a suite of technologies that can be selectively deployed to develop targeted cellular therapies for patients with cancer. The company is advancing multiple preclinical and clinical programs in oncology. The firm's lead preclinical programs in B cell non-Hodgkin's lymphoma (B-NHL) and acute myeloid leukemia are illustrations of its multiplex approach applied to address the specific challenges of treating those cancers. The company is developing bbT369 product candidate as a treatment for patients with B-NHL.

Contact

MASSACHUSETTS
Cambridge
60 Binney Street
+13394999300.0

IPO

2021-10-18

Employees

437

Officers

CEO, President & Director
Mr. William D. Baird III, M.B.A.
Chief Financial Officer
Ms. Victoria Eatwell
Senior VP of Quality and Head of Operations
Ms. Jessica Snow
Chief Medical Officer
Dr. Anna Truppel-Hartmann M.D.

See Also

Discover More
What is the Intrinsic Value of one TSVT stock?

The intrinsic value of one TSVT stock under the Base Case scenario is 4.619 USD.

Is TSVT stock undervalued or overvalued?

Compared to the current market price of 4.005 USD, 2Seventy Bio Inc is Undervalued by 13%.

Back to Top